Model Registration: A Call to Action.
作者信息
Sampson Christopher James, Wrightson Tim
机构信息
Division of Rehabilitation and Ageing, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK.
Adis International Ltd, Auckland, New Zealand.
出版信息
Pharmacoecon Open. 2017 Jun;1(2):73-77. doi: 10.1007/s41669-017-0019-2.
Abstract
摘要
相似文献
1
Model Registration: A Call to Action.
Pharmacoecon Open. 2017 Jun;1(2):73-77. doi: 10.1007/s41669-017-0019-2.
2
Effectiveness and cost-effectiveness of telephone consultations for fever or gastroenteritis using a formalised procedure in general practice: study protocol of a cluster randomised controlled trial.
Trials. 2016 Sep 22;17(1):461. doi: 10.1186/s13063-016-1585-9.
3
QUADRATIC: Quality of Dice in Registration Circuits.
Proc SPIE Int Soc Opt Eng. 2018 Mar;10574. doi: 10.1117/12.2293642.
4
Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial.
Trials. 2016 Apr 30;17(1):225. doi: 10.1186/s13063-016-1350-0.
5
The YOU CALL-WE CALL randomized clinical trial: Impact of a multimodal support intervention after a mild stroke.
Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):674-9. doi: 10.1161/CIRCOUTCOMES.113.000375. Epub 2013 Nov 12.
6
To call or not to call: a judgement of risk by pre-registration house officers.
Med Educ. 2008 Sep;42(9):938-44. doi: 10.1111/j.1365-2923.2008.03123.x.
7
Conclusions: Calls to action for improving the life of MS patients and their families.
Mult Scler. 2016 Aug;22(2 Suppl):71-7. doi: 10.1177/1352458516650738.
8
Hereditary angioedema, emergency management of attacks by a call center.
Eur J Intern Med. 2019 Sep;67:42-46. doi: 10.1016/j.ejim.2019.05.007. Epub 2019 May 18.
9
Bayesian technique for image classifying registration.
IEEE Trans Image Process. 2012 Sep;21(9):4080-91. doi: 10.1109/TIP.2012.2200495. Epub 2012 May 22.
10
Simulation-based education (SBE) within postgraduate emergency on-call physiotherapy in the United Kingdom.
Nurse Educ Today. 2013 Aug;33(8):778-84. doi: 10.1016/j.nedt.2012.03.015. Epub 2012 Apr 18.
引用本文的文献
1
A meta-epidemiological assessment of transparency indicators of infectious disease models.
PLoS One. 2022 Oct 7;17(10):e0275380. doi: 10.1371/journal.pone.0275380. eCollection 2022.
2
Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network.
Pharmacoeconomics. 2022 Oct;40(10):1005-1009. doi: 10.1007/s40273-022-01179-x. Epub 2022 Jul 30.
3
Simulation modeling validity and utility in colorectal cancer screening delivery: A systematic review.
J Am Med Inform Assoc. 2020 Jun 1;27(6):908-916. doi: 10.1093/jamia/ocaa022.
4
Registered Reports: Time to Radically Rethink Peer Review in Health Economics.
Pharmacoecon Open. 2020 Mar;4(1):1-4. doi: 10.1007/s41669-019-00190-x.
5
Economic evaluation of meningococcal vaccines: considerations for the future.
Eur J Health Econ. 2020 Mar;21(2):297-309. doi: 10.1007/s10198-019-01129-z. Epub 2019 Nov 21.
6
A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling.
Pharmacoeconomics. 2019 Nov;37(11):1329-1339. doi: 10.1007/s40273-019-00837-x.
7
Can You Repeat That? Exploring the Definition of a Successful Model Replication in Health Economics.
Pharmacoeconomics. 2019 Nov;37(11):1371-1381. doi: 10.1007/s40273-019-00836-y.
8
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.
Pharmacoeconomics. 2019 Nov;37(11):1305-1312. doi: 10.1007/s40273-019-00825-1.
9
Transparency in Decision Modelling: What, Why, Who and How?
Pharmacoeconomics. 2019 Nov;37(11):1355-1369. doi: 10.1007/s40273-019-00819-z.
10
Publication of Decision Model Source Code: Attitudes of Health Economics Authors.
Pharmacoeconomics. 2019 Nov;37(11):1409-1410. doi: 10.1007/s40273-019-00796-3.
本文引用的文献
1
Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review.
Pharmacoecon Open. 2017 Sep;1(3):149-165. doi: 10.1007/s41669-017-0014-7.
2
Benefits, Challenges and Potential Strategies of Open Source Health Economic Models.
Pharmacoeconomics. 2017 Jan;35(1):125-128. doi: 10.1007/s40273-016-0479-8.
3
Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy.
Pharmacoeconomics. 2017 Feb;35(2):163-176. doi: 10.1007/s40273-016-0460-6.
4
Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer.
Pharmacoeconomics. 2016 Sep;34(9):833-45. doi: 10.1007/s40273-016-0410-3.
5
Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics.
Pharmacoeconomics. 2016 Jul;34(7):665-72. doi: 10.1007/s40273-016-0394-z.
6
Use and mis-use of supplementary material in science publications.
BMC Bioinformatics. 2015 Nov 3;16:237. doi: 10.1186/s12859-015-0668-z.
7
The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.
Pharmacoeconomics. 2015 Oct;33(10):993-1011. doi: 10.1007/s40273-015-0312-9.
8
Editorial statement on negative findings.
J Health Econ. 2015 Jul;42:A1. doi: 10.1016/j.jhealeco.2015.06.002.
9
Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.
Health Qual Life Outcomes. 2013 Sep 5;11:151. doi: 10.1186/1477-7525-11-151.
10
Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.
Value Health. 2013 Jun;16(4):670-85. doi: 10.1016/j.jval.2013.01.002. Epub 2013 Apr 18.
Zotero 插件